Skip to main content

Table 3 Surgical findings for the patients received radical surgery after chemotherapy (N = 176)

From: Efficacy after preoperative capecitabine and oxaliplatin (XELOX) versus docetaxel, oxaliplatin and S1 (DOS) in patients with locally advanced gastric adenocarcinoma: a propensity score matching analysis

  XELOX group
(n = 111)
DOS group
(n = 65)
P
Pathological response
 Responders 59 (53.1) 48 (73.8) 0.010
 pCR 10 (9.0) 8 (12.9) 0.685
Median total nodes 30 (2–75) 34 (9–71)  
Median positive nodes 4 (0–62) 2 (0–30)  
Median time from end of treatment to surgery 29 (16–38) 30 (17–42)  
Median time from surgery to discharge 11 (6–39) 13 (5–43)  
Pathological T stage
 ypT0 13 (11.7) 9 (13.8) 0.623
 ypT1 14 (12.6) 7 (10.7) 0.715
 ypT2 13 (11.7) 12 (18.5) 0.215
 ypT3 35 (31.5) 26 (40.0) 0.254
 ypT4 36 (32.5) 11 (17.0) 0.024
 Combined ypT0/ypT1/ypT2/ypT3 75 (67.5) 54 (83.0) 0.038
Pathological N stage
 ypN0 (no regional lymph nodes) 35 (31.5) 26 (40.0) 0.329
 ypN1 (1–2 positive lymph nodes) 17 (15.3) 12 (18.5) 0.739
 ypN2 (3–6 positive lymph nodes) 23 (20.7) 10 (16.1) 0.499
 ypN3 (> 6 positive lymph nodes) 36 (32.5) 17 (28.4) 0.480